These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 10699962)
1. Multiple functions of p27(Kip1) and its alterations in tumor cells: a review. Sgambato A; Cittadini A; Faraglia B; Weinstein IB J Cell Physiol; 2000 Apr; 183(1):18-27. PubMed ID: 10699962 [TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Kawamata N; Morosetti R; Miller CW; Park D; Spirin KS; Nakamaki T; Takeuchi S; Hatta Y; Simpson J; Wilcyznski S Cancer Res; 1995 Jun; 55(11):2266-9. PubMed ID: 7757974 [TBL] [Abstract][Full Text] [Related]
3. p27 Expression, a cyclin dependent kinase inhibitor in breast carcinoma. Barbareschi M Adv Clin Path; 1999 Oct; 3(4):119-27. PubMed ID: 10936889 [TBL] [Abstract][Full Text] [Related]
4. p27: a pleiotropic regulator of cellular phenotype and a target for cell cycle dysregulation in cancer. Desdouets C; Bréchot C Pathol Biol (Paris); 2000 Apr; 48(3):203-10. PubMed ID: 10858954 [TBL] [Abstract][Full Text] [Related]
5. STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1). de Koning JP; Soede-Bobok AA; Ward AC; Schelen AM; Antonissen C; van Leeuwen D; Löwenberg B; Touw IP Oncogene; 2000 Jul; 19(29):3290-8. PubMed ID: 10918585 [TBL] [Abstract][Full Text] [Related]
6. p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Philipp-Staheli J; Payne SR; Kemp CJ Exp Cell Res; 2001 Mar; 264(1):148-68. PubMed ID: 11237531 [TBL] [Abstract][Full Text] [Related]
7. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1. Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671 [TBL] [Abstract][Full Text] [Related]
8. Regulation of the cdk inhibitor p27 and its deregulation in cancer. Slingerland J; Pagano M J Cell Physiol; 2000 Apr; 183(1):10-7. PubMed ID: 10699961 [TBL] [Abstract][Full Text] [Related]
9. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade. Guo Y; Sklar GN; Borkowski A; Kyprianou N Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624 [TBL] [Abstract][Full Text] [Related]
10. p27 modulates cell cycle progression and chemosensitivity in human malignant glioma. Naumann U; Weit S; Rieger L; Meyermann R; Weller M Biochem Biophys Res Commun; 1999 Aug; 261(3):890-6. PubMed ID: 10441521 [TBL] [Abstract][Full Text] [Related]
11. Osteoclast differentiation is associated with transient upregulation of cyclin-dependent kinase inhibitors p21(WAF1/CIP1) and p27(KIP1). Okahashi N; Murase Y; Koseki T; Sato T; Yamato K; Nishihara T J Cell Biochem; 2001; 80(3):339-45. PubMed ID: 11135363 [TBL] [Abstract][Full Text] [Related]
12. p27/Kip1 mutation found in breast cancer. Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318 [TBL] [Abstract][Full Text] [Related]
13. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours. Dahia PL; Aguiar RC; Honegger J; Fahlbush R; Jordan S; Lowe DG; Lu X; Clayton RN; Besser GM; Grossman AB Oncogene; 1998 Jan; 16(1):69-76. PubMed ID: 9467944 [TBL] [Abstract][Full Text] [Related]
14. Alterations in the expression of the cell cycle regulatory protein cyclin kinase subunit 1 in colorectal carcinoma. Shapira M; Ben-Izhak O; Bishara B; Futerman B; Minkov I; Krausz MM; Pagano M; Hershko DD Cancer; 2004 Apr; 100(8):1615-21. PubMed ID: 15073847 [TBL] [Abstract][Full Text] [Related]
15. Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27(Kip1). Katner AL; Hoang QB; Gootam P; Jaruga E; Ma Q; Gnarra J; Rayford W Prostate; 2002 Sep; 53(1):77-87. PubMed ID: 12210483 [TBL] [Abstract][Full Text] [Related]
16. Expression of p27(Kip1) protein in transitional cell carcinoma of the upper urinary tract. Nakanishi K; Kawai T; Aida S; Kasamatsu H; Aurues T; Ikeda T Mod Pathol; 2001 May; 14(5):371-6. PubMed ID: 11353044 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer. Vis AN; Noordzij MA; Fitoz K; Wildhagen MF; Schröder FH; van der Kwast TH J Urol; 2000 Dec; 164(6):2156-61. PubMed ID: 11061947 [TBL] [Abstract][Full Text] [Related]
18. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Agarwal C; Singh RP; Dhanalakshmi S; Tyagi AK; Tecklenburg M; Sclafani RA; Agarwal R Oncogene; 2003 Nov; 22(51):8271-82. PubMed ID: 14614451 [TBL] [Abstract][Full Text] [Related]
19. P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution. Grimison B; Langan TA; Sclafani RA Cell Growth Differ; 2000 Oct; 11(10):507-15. PubMed ID: 11063124 [TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor (HGF) inhibits skeletal muscle cell differentiation: a role for the bHLH protein twist and the cdk inhibitor p27. Leshem Y; Spicer DB; Gal-Levi R; Halevy O J Cell Physiol; 2000 Jul; 184(1):101-9. PubMed ID: 10825239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]